China is tightening regulatory oversight on companies with 'Chinese DNA' — even if they are legally based overseas. In April 2026, authorities blocked Meta’s proposed acquisition of Manus, a Chinese-origin AI startup that rebranded as a Singaporean firm, citing national security and the need for proper risk evaluation. This move signals a broader shift: Beijing now applies 'substance over form' scrutiny to corporate structures, targeting offshore re-domiciliation used to bypass tax, capital, and data rules. The government is extending look-through regulation beyond capital markets to include technology, talent, and intellectual property.

The crackdown follows a sharp drop in Hong Kong IPOs by red-chip companies — firms with offshore holding structures — from around 30% of listings in 2025 to less than 5% in early 2026. Regulators are now demanding that such firms repatriate overseas-raised funds or file for approval, while tax authorities use international data-sharing tools like the Common Reporting Standard to track offshore trusts and shell companies. High-profile cases, like Evergrande’s offshore wealth transfers, have exposed how these structures enabled capital flight.

Beijing’s stance reflects a departure from the 'borderless capital' mindset of the globalization era. Authorities emphasize compliance and transparency, warning firms that origin-washing won’t shield them from oversight. For global investors and entrepreneurs, the message is clear: if your technology, team, or operations are rooted in China, regulatory reach extends far beyond jurisdictional borders.